参考资料:

[1]. Chistenson et al. (2020). Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future. Lancet Oncology, DOI:https://doi.org/10.1016/S1470-2045(19)30795-8

[2] Liu et al., (2019). Targeting the untargetable KRAS in cancer therapy. Acta Pharmaceutica Sinica B, https://doi.org/10.1016/j.apsb.2019.03.002

（注：原文有删减）

原标题：《柳叶刀》子刊综述: 征服“癌症之王”，未来5-10年有望获得重大突破

▽关注【药明康德】微信公众号